Search results
Pandemrix is an influenza vaccine for influenza pandemics, such as the 2009 flu pandemic. The vaccine was developed by GlaxoSmithKline (GSK) [2] and patented in September 2006. [3] The vaccine was one of the H1N1 vaccines approved for use by the European Commission in September 2009, upon the recommendations of the European Medicines Agency ...
They contain inactivated purified surface fragments (subunits) from the three different strains of the influenza virus (A/H1N1, A/H3N2, and Influenza B virus) that are selected and distributed by the World Health Organization, on the basis of their latest recommendations.
26 mar 2024 · Manufacturers of live-attenuated vaccines, or egg-based trivalent vaccines should include these three virus strains for the 2024/2025 season: an A/Victoria/4897/2022 (H1N1)pdm09-like virus; an A/Thailand/8/2022 (H3N2)-like virus;
5 wrz 2024 · A recent study showed that a seasonal quadrivalent influenza mRNA-1010 vaccine encoding four haemagglutinin proteins (H1N1, H3N2, B/Victoria, and B/Yamagata) was safe for healthy adults over 18 years of age and induced superior haemagglutinin inhibition antibody titres to influenza A components compared with a standard inactivated seasonal ...
31 sie 2022 · In July 2022, Emergex Vaccines Holding Limited through the development of fully synthetic CD8+ T cell Adaptive Vaccines, announced the manufacture of its universal/pandemic influenza vaccine ...
14 mar 2024 · Trivalent flu vaccines are formulated to protect against three flu viruses (an A(H1N1) virus, an A(H3N2) virus, and a B/Victoria virus). Trivalent flu vaccines are approved for use in many countries. Both trivalent and quadrivalent flu vaccines are expected to offer similar protection against the flu viruses they protect against.
Four pandemic preparedness vaccines are currently authorised in the EU, which can be modified into pandemic influenza vaccines in a future pandemic: Foclivia; Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)
